1Zelefsky MJ,Whitmore WF Jr.Long-term results of retropubicpermanent 1-125 implantation of the prostate for clinically localized prostate cancer[J].J Urol, 1997,158(1), 29-30.
2Tsui G,Glllan C,Pond G,et al.Posttreatment complications of early—stage prostate cancer patients : brachytherapy versus three-dimensional conformal radiation therapy!J].Cancer J, 2005,il(2):I22-132.
6Stone NN ’ Stock RG,U hger P. Intermediate term biochemical-free progression and local control following 125 iodine brachytherapy for prostate cancer[J].J Urol,2005,173(3):803-807.
7Potters L.Morgenstem C, Calugaru E,et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer[J].J Urol,2008,179(5):S20—24.
8Zelefsky MJ, Yamada Y,Cohen GN,et al.Five-year outcome of initraoperative conformal permanent 1-125 interstitial implantation for patients with clinically localized prostate cancer[J].Int J Radiat Oncol Biol Phys,2007,67(1):65- 70.
9Critz FA,Levinson K.Ten-year disease-free survival rates after simultaneous irradiation for prostate cancer with a focus on calculation methodology!J]. J Urol,2004,172(6): 2232-2238.
10Battermann JJ,Boon TA,Moerland MA.Results of permanent prostate brachytherapy, 13 years of experience as a single institution[J].Radiother Oncol, 2004,71(1):23-28.
9Zelefsky M J, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys,2007, 67:327-333.
10Ragde H,Elgamal AA,Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized,low to high Gleason grade prostate carcinoma. Cancer, 1998,83:989-1001.
